HTC supports Geneva-based startup

ORamaVR was founded in 2016 in Greece as a spin-off company of the Foundation for Research and Technology-Hellas and received initial pre-seed funding from PJTCF VC. The startup offers health care education VR simulations that can be targeted to specific operations, such as hip, knee, and dental procedures, as well as broader training on topics like emergency trauma and basic clinical skills.

The company has recently moved its headquarters to Geneva – where one of its co-founders and CTO, George Papagiannakis, earned his PhD back in 2006 – to meet the growing demand for its medical VR training software in Switzerland. ORamaVR is also present in Silicon Valley with close collaborations with Stanford University and SRI.

“Western Switzerland has an excellent reputation as a leading life science and tech hub. Our new headquarters in Geneva offers exceptional possibilities for collaboration and influence, given the city’s unparalleled concentration of international organizations and other prestigious institutions,” said Paolo A. Catilo, Co-founder and CEO of ORamaVR. “The assistance provided by GGBa and DG DERI was instrumental in the rapid and smooth incorporation of our new Swiss entity. Both agencies facilitated our access to the region’s innovation and entrepreneurship community. Thanks to their ongoing support, new collaboration opportunities are on the horizon.”

Participation in HTC’s Vive X accelerator

While the company has just settled in at its new main address, ORamaVR has started building its track record. The company has been selected as one of the seven companies to be supported by HTC as part of the Vive X accelerator program. HTC created a $100 million fund for VR startups called Vive X, to grow both applications and use cases for its then-new Vive VR headset. Htc Vive X fold focuses substantially but not exclusively on enterprise XR solutions.

(RAN)